Your browser doesn't support javascript.
loading
Author Correction: Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
Zhang, Zhenlei; Wu, Yufan; Fu, Jinrong; Yu, Xiujie; Su, Yang; Jia, Shikai; Cheng, Huili; Shen, Yan; He, Xianghui; Ren, Kai; Zheng, Xiangqian; Guan, Haixia; Rao, Feng; Zhao, Li.
Affiliation
  • Zhang Z; Department of Thyroid and Neck Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Imm
  • Wu Y; Department of Thyroid and Neck Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Imm
  • Fu J; Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
  • Yu X; Department of Pathology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, China.
  • Su Y; School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Jia S; Department of Thyroid and Neck Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Imm
  • Cheng H; Department of Thyroid and Neck Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Imm
  • Shen Y; Department of Pathology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, China.
  • He X; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Ren K; Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Zheng X; Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Guan H; Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China. guanhaixia@gdph.org.cn.
  • Rao F; School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong, China. raof@sustech.edu.cn.
  • Zhao L; Department of Thyroid and Neck Tumor, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune
Nat Commun ; 15(1): 4936, 2024 Jun 10.
Article in En | MEDLINE | ID: mdl-38858379
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2024 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2024 Document type: Article Country of publication: Reino Unido